|
|||||
|
|
Cost‐effectiveness analysis of lapatinib in HER‐2–positive advanced breast cancer |
|
| Abstract: | |
| Keywords: | economics cost‐effectiveness analysis cost‐utility analysis lapatinib Tykerb HER‐2 metastatic breast cancer advanced breast cancer ICER |
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
|
|
|
| 设为首页 | 免责声明 | 关于勤云 | 加入收藏 |
|
Copyright©北京勤云科技发展有限公司 京ICP备09084417号 |